Does a large-scale RNAi-based mouse tumorigenesis screen identify new lung cancer tumor suppressors that repress FGFR signaling?
A functional genomics approach identifies new lung TSGs whose loss aberrantly increases FGFR signaling to promote tumorigenesis. These TSGs are frequently downregulated in hLSCCs, indicating that increased FGFR signaling promotes tumorigenesis in many hLSCCs lacking FGFR1 amplification or activating mutations.
Urine alkalization therapy is likely to be effective in the treatment for hypersensitive bladder syndrome.